Day One Biopharmaceuticals Holding Co LLC (10)

Browse by Contract Category

Contracts

Form of Plan of Conversion (Filed With SEC on May 4, 2021)
Amended and Restated Investors Rights Agreement, dated February 1, 2021, by and among the Registrant and certain of its stockholders (Filed With SEC on May 4, 2021)
Form of Indemnification Agreement with directors and officers (Filed With SEC on May 4, 2021)
2021 Equity Incentive Plan and forms of award agreements (Filed With SEC on May 4, 2021)
Office Lease, dated February 8, 2020, by and between Kashiwa Fudosan America, Inc. and Day One Therapeutics, Inc (Filed With SEC on May 4, 2021)
Asset Transfer and License Agreement, effective as of December 16, 2019, by and between DOT Therapeutics-1, Inc. and Millennium Pharmaceuticals, Inc (Filed With SEC on May 4, 2021)
2021 Employee Stock Purchase Plan and forms of award agreements (Filed With SEC on May 4, 2021)
License Agreement for RAF, effective as of December 16, 2019, by and between Sunesis Pharmaceuticals, Inc. and DOT Therapeutics-1, Inc (Filed With SEC on May 4, 2021)
License Agreement, dated February 10, 2021, by and between Merck KGaA, Darmstadt, Germany and Day One Biopharmaceuticals, Inc (Filed With SEC on May 4, 2021)
Stock Exchange Agreement, dated May 4, 2021, by and between Day One BioPharmaceuticals Holding Co., LLC and Millennium Pharmaceuticals, Inc (Filed With SEC on May 4, 2021)